Profile of PEGylated interferon beta in the treatment of relapsing-remitting multiple sclerosis
Eleonora Cocco, Maria Giovanna Marrosu Multiple Sclerosis Center, Department of Public Health, Clinical and Molecular Medicine, University of Cagliari, Cagliari, Italy Abstract: Several treatments are currently available for relapsing-remitting multiple sclerosis. Among them, interferon (IFN) beta r...
Saved in:
Main Authors: | Cocco E (Author), Marrosu MG (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2015-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Response to treatment with Interferon beta-1a in patients with relapsing-remitting multiple sclerosis
by: Làzaro Aurelio Vàzquez Gòmez, et al.
Published: (2022) -
Cost-utility analysis of interferon beta-1a (Avonex and Cinnovex) for relapsing remitting multiple sclerosis
by: Rahil Sadat Shahtaheri, et al.
Published: (2018) -
Influence of histocompatibility genes on disease susceptibility and treatment response in patients with relapsing-remitting multiple sclerosis treated with interferon beta-1a
by: Shlomo Flechter, et al.
Published: (2011) -
A multicentric pharmacovigilance study: collection and analysis of adverse drug reactions in relapsing-remitting multiple sclerosis patients
by: Gugliandolo A, et al.
Published: (2018) -
Injectable interferon beta-1b for the treatment of relapsing forms of multiple sclerosis
by: Slobodan M Jankovic
Published: (2010)